Genentech Releases SMA Community Letter

December 30, 2022 / No Comments / ,

Genentech, a member of the Roche Group, logo

Our industry partners at Genentech recently released an SMA community letter summarizing 2022 developments and initiates. Check it out here!

Do you like what you're reading?

Help make a difference in the lives of people affected by spinal muscular atrophy.

Posted in ,

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
<!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: SMAAM Lightbox #2 --> <script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,291506,'nlbergwrhtqnmjvuvg7q');</script> <!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: Basic Research Grants --> <script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,291506,'idozqmam4bpvlvdmsvzd');</script> <!-- / OptinMonster -->